DR. MARTENS PLC LS -,01DR. MARTENS PLC LS -,01DR. MARTENS PLC LS -,01

DR. MARTENS PLC LS -,01

No trades
See on Supercharts
Next report date
Report period
H2 2023
EPS estimate
0.06EUR
Revenue estimate
‪577.76 M‬EUR
Market capitalization
‪883.49 M‬EUR
‪146.68 M‬EUR
‪1.14 B‬EUR
‪555.95 M‬
Beta (1Y)
2.12

About DR. MARTENS PLC ORD GBP0.01

CEO
Kenneth Charles Wilson
Headquarters
London
Employees (FY)
‪2.59 K‬
Founded
1945
ISIN
GB00BL6NGV24
FIGI
BBG00Z3SMBJ8
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 3U2 is featured.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange DR. MARTENS PLC LS -,01 stocks are traded under the ticker 3U2.
DR. MARTENS PLC LS -,01 is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
3U2 earnings for the last quarter are 0.10 EUR per share, whereas the estimation was 0.11 EUR resulting in a −13.97% surprise. The estimated earnings for the next quarter are 0.02 EUR per share. See more details about DR. MARTENS PLC LS -,01 earnings.
DR. MARTENS PLC LS -,01 revenue for the last quarter amounts to ‪662.10 M‬ EUR despite the estimated figure of ‪660.95 M‬ EUR. In the next quarter revenue is expected to reach ‪459.69 M‬ EUR.
Yes, you can track DR. MARTENS PLC LS -,01 financials in yearly and quarterly reports right on TradingView.
3U2 net income for the last quarter is ‪21.92 M‬ EUR, while the quarter before that showed ‪95.81 M‬ EUR of net income which accounts for −77.12% change. Track more DR. MARTENS PLC LS -,01 financial stats to get the full picture.
DR. MARTENS PLC LS -,01 dividend yield was 4.10% in 2022, and payout ratio reached 45.34%. The year before the numbers were 2.30% and 30.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 3U2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. MARTENS PLC LS -,01 stock right from TradingView charts — choose your broker and connect to your account.
3U2 reached its all-time high on Feb 8, 2021 with the price of 6.230 EUR, and its all-time low was 0.340 EUR and was reached on Sep 24, 2007. View more price dynamics on 3U2 chart.
See other stocks reaching their highest and lowest prices.
As of May 4, 2024, the company has ‪2.59 K‬ employees. See our rating of the largest employees — is DR. MARTENS PLC LS -,01 on this list?
We've gathered analysts' opinions on DR. MARTENS PLC LS -,01 future price: according to them, 3U2 price has a max estimate of 1.29 EUR and a min estimate of 0.76 EUR. Watch 3U2 chart and read a more detailed DR. MARTENS PLC LS -,01 stock forecast: see what analysts think of DR. MARTENS PLC LS -,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. MARTENS PLC LS -,01 EBITDA is ‪269.07 M‬ EUR, and current EBITDA margin is 24.49%. See more stats in DR. MARTENS PLC LS -,01 financial statements.